Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

ABBV-467 is an inhibitor of myeloid cell leukemia-1 (Mcl-1; Ki = <0.1 nM).1 It is selective for Mcl-1 over Bcl-2, Bcl-xL, Bcl-W, and Bcl-2-A1 (Kis = >642, >376, >247, and >402 nM, respectively). ABBV-467 reduces the viability of AMO1, NCI H929, and MV4-11 myeloma cells (EC50s = 0.16, 0.47, and 3.91 nM, respectively). In vivo, ABBV-467 (3.13, 6.25, and 12.5 mg/kg) reduces tumor growth in an AMO1 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Selective MCL-